FAM
KZR

Fred Alger Management’s Kezar Life Sciences KZR Stock Holding History

Fred Alger Management’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-17,070
Closed -$2.84M – 528
2022
Q1 		$2.84M Buy
+17,070
New +$2.45M 0.01% 319
2019
Q2 		– Sell
-1,800
Closed -$319K – 536
2019
Q1 		$319K Buy
1,800
+200
+13% +$39.4K ﹤0.01% 385
2018
Q4 		$378K Buy
+1,600
New +$391K ﹤0.01% 365

Other funds holding KZR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Fred Alger Management's KZR Position: Q2 2022 in Review

Fred Alger Management sold out of Kezar Life Sciences (KZR) in Q2 2022, closing a stake of 17,070 shares — an estimated $2.84M sold.

Fred Alger Management first reported a position in KZR in Q4 2018 and held it in 3 quarters. The position peaked at $2.84M in Q1 2022. 127 funds tracked by Wall St. Rank hold KZR as of Q2 2022.

  • Fred Alger Management reported no remaining Kezar Life Sciences position as of Q2 2022 after selling out during the quarter.
  • Fred Alger Management sold 17,070 Kezar Life Sciences shares in Q2 2022, an estimated $2.84M.
  • Fred Alger Management first reported a position in Kezar Life Sciences in Q4 2018 and held it in 3 quarters.
  • Fred Alger Management's Kezar Life Sciences position peaked at $2.84M in Q1 2022.
  • 127 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q2 2022.

Based on Fred Alger Management's 13F filing for Q2 2022, filed 15 Aug 2022.